Search results
Results from the WOW.Com Content Network
C61 is the code for malignant neoplasm of prostate, a common cancer among older men. Learn the coding rules, exclusions, synonyms, clinical information, and diagnostic related groups for this code.
Find the ICD-10-CM codes for malignant neoplasm of prostate, including hormone sensitivity status, rising PSA following treatment, and exclusions. Learn about the clinical information, symptoms, diagnosis, and treatment of prostate cancer.
C61 is a billable diagnosis code for male patients with prostate cancer. It includes various histological types, stages, and extensions of the tumor, and is linked to quality measures and MS-DRG mapping.
Z12.5 is a billable code for male patients who encounter health services for screening for malignant neoplasm of prostate. It is applicable to prostate cancer screening exams and not to other genitourinary organs or sites.
Learn the official long descriptor, exclusions, and forum discussions for ICD-10-CM code C61, which is used to classify malignant neoplasm of prostate. Find out how to code for hormone sensitivity status, rising PSA, and prostate recurrence.
Find the diagnosis codes for malignant neoplasm of prostate (C61) and related conditions, such as hormone sensitivity status and rising PSA. Learn how to use additional codes, excludes notes and filter codes by section.
C61 is a valid billable diagnosis code for prostate cancer in males, excluding seminal vesicle tumors. It is found in the 2024 version of the ICD-10 Clinical Modification and has specific coding rules and exclusions.
C61 is the ICD-10-CM code for malignant neoplasm of prostate, a type of prostate cancer. Learn about the symptoms, causes, diagnosis, and treatment of prostate cancer, and how to code it for medical billing and insurance purposes.
Use additional code: code to identify: hormone sensitivity status (Z19.1-Z19.2) rising PSA following treatment for malignant neoplasm of prostate (R97.21)
C61 is the code for malignant neoplasm of prostate in the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM). Learn how to use additional codes to specify hormone sensitivity status or rising PSA following treatment.